Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TENOFOVIR DISOPROXIL Cause Epistaxis? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Epistaxis have been filed in association with TENOFOVIR DISOPROXIL (Tenofovir Disoproxil Fumarate). This represents 0.0% of all adverse event reports for TENOFOVIR DISOPROXIL.

9
Reports of Epistaxis with TENOFOVIR DISOPROXIL
0.0%
of all TENOFOVIR DISOPROXIL reports
1
Deaths
8
Hospitalizations

How Dangerous Is Epistaxis From TENOFOVIR DISOPROXIL?

Of the 9 reports, 1 (11.1%) resulted in death, 8 (88.9%) required hospitalization, and 1 (11.1%) were considered life-threatening.

Is Epistaxis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TENOFOVIR DISOPROXIL. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does TENOFOVIR DISOPROXIL Cause?

Bone density decreased (10,586) Renal injury (9,255) Skeletal injury (8,320) Chronic kidney disease (7,230) Osteonecrosis (7,182) Bone loss (7,040) Multiple fractures (6,793) Renal failure (6,388) Osteoporosis (5,302) Tooth loss (4,483)

What Other Drugs Cause Epistaxis?

RIVAROXABAN (5,629) ASPIRIN (3,214) APIXABAN (2,831) FLUTICASONE (1,745) TREPROSTINIL (1,726) CLOPIDOGREL BISULFATE (1,560) BEVACIZUMAB (1,542) WARFARIN (1,498) PALBOCICLIB (1,280) ADALIMUMAB (1,243)

Which TENOFOVIR DISOPROXIL Alternatives Have Lower Epistaxis Risk?

TENOFOVIR DISOPROXIL vs TEPLIZUMAB-MZWV TENOFOVIR DISOPROXIL vs TEPOTINIB TENOFOVIR DISOPROXIL vs TEPROTUMUMAB TENOFOVIR DISOPROXIL vs TEPROTUMUMAB-TRBW TENOFOVIR DISOPROXIL vs TERAZOSIN

Related Pages

TENOFOVIR DISOPROXIL Full Profile All Epistaxis Reports All Drugs Causing Epistaxis TENOFOVIR DISOPROXIL Demographics